Revolution Medicines $750 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
PG&E $2.76 billion common and preferred share offerings
The common stock is, and the preferred stock will be, listed on the NYSE
indie Semiconductor $218.5 million convertible senior notes offering
The 3.5% convertible senior notes are due 2029
Fastly $150 million convertible senior notes offering
The 7.75% convertible notes are due 2028
Enviva emerges from chapter 11
We advised an ad hoc group of creditors in connection with Enviva’s chapter 11 proceedings
Citi acquisition of Barclays American Airlines co-branded card portfolio
We are advising Citi on the acquisition
Avon Products bankruptcy court approval of Natura settlement and $125 million sale
We are advising Natura on its settlement with the Avon debtors and purchase of the Avon International business
AppLovin $1 billion revolving credit facility
We advised the administrative agent and joint lead arrangers on the facility
PAR Technology private exchange
$100 million aggregate principal amount of existing convertible senior notes were exchanged
Ark & Partners tender offer for Soomgo
We advised Ark & Partners on the transaction